Canada markets close in 4 hours 24 minutes

Elevation Oncology, Inc. (ELEV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.5300+0.0500 (+1.44%)
As of 11:35AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 190.69M
Enterprise Value 117.45M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.52
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.96

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-8.42%
S&P500 52-Week Change 325.38%
52 Week High 35.8900
52 Week Low 30.3630
50-Day Moving Average 34.3665
200-Day Moving Average 31.9430

Share Statistics

Avg Vol (3 month) 31.01M
Avg Vol (10 day) 31.16M
Shares Outstanding 554.64M
Implied Shares Outstanding 654.64M
Float 825.15M
% Held by Insiders 11.75%
% Held by Institutions 176.99%
Shares Short (Apr 15, 2024) 44.95M
Short Ratio (Apr 15, 2024) 45.76
Short % of Float (Apr 15, 2024) 411.32%
Short % of Shares Outstanding (Apr 15, 2024) 410.18%
Shares Short (prior month Mar 15, 2024) 44.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.94%
Return on Equity (ttm)-71.82%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.53M
Net Income Avi to Common (ttm)-39.35M
Diluted EPS (ttm)-0.8500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.05M
Total Cash Per Share (mrq)1.9
Total Debt (mrq)30.81M
Total Debt/Equity (mrq)40.63%
Current Ratio (mrq)46.22
Book Value Per Share (mrq)1.47

Cash Flow Statement

Operating Cash Flow (ttm)-48.92M
Levered Free Cash Flow (ttm)-36.49M